The 7th Annual Molecular Psychiatry Meeting
Hyatt Regency San Francisco
San Francisco, California
October 17 – 19, 2019
We are pleased to announce that the 7th Annual Molecular Psychiatry Meeting will take place October 17 -19, 2019 in San Francisco, Calfiornia. All researchers interested in learning about molecular approaches to enhance understanding of psychiatric disease are invited to attend this open meeting. Sessions will include neurobiology, genetics, biomarkers, brain expression, neural stem cells and model organisms. A poster session will also be held. The meeting will take place at the Hyatt Regency San Francisco.
REGISTRATION WILL OPEN IN MARCH 2019.
- Investigators: $495 until August 1st. $695 after August 01, 2019
- Student/Postdoc Participant/Medical Resident: $150 until August 1st. $200 after August 01, 2019
Costs of registration includes a one year membership to the Molecular Psychiatry Association and free online access to Molecular Neuropsychiatry.
Hyatt Regency San Francisco
5 Embarcadero Center, San Francisco, CA 94111
Please note attendees must reserve their hotel rooms by Monday, September 16, 2019 to qualify for the discounted conference rate. There is limited availability, please book early.
2019 Annual Molecular Psychiatry Meeting Sessions Titles and Chairs will be announced soon.
2018 Annual Molecular Psychiatry Meeting Sessions Titles and Chairs
- New Molecular and Circuit-Level Approaches for Understanding the Effects of Chronic Stress in the Mammalian Brain, Stephan Lammel, University of California, Berkeley
- Utilizing Diversity of Model Organisms for Studying the Molecular Basis of Neuropsychiatric Disorder, Michael Yartsev, University of California, Berkeley
- The Neural Circuitry Underlying Social Dysfunction, Byungkook Lim, University of California, San Diego
- Diseases of the Social Brain, Gul Dolen, Johns Hopkins University
- Calcium Mechanisms in Bipolar Disorder: A Review of Genetic Evidence and Cellular Models, John Nurnberger, Indiana University
- iPSC-based Platform Development for Major Psychiatric Disorder Modeling and Discovery, Guang Chen, Janssen R&D
- Molecular Mechanisms of Pain Regulation, Tom Kash, University of North Carolina
- Building on Advances in Genetics to Validate Novel Molecular Targets for Treatment of Schizophrenia, Jeff Conn, Vanderbilt University
- Cortico-striatal Circuits in Addiction and Compulsion, Susanne Ahmari, University of Pittsburgh
- Central and Peripheral Actions of Insulin: Implications for Psychiatric Disorders, Michael McCarthy, University of California, San Diego
- The Application of Stem Cell Models to Validate Rare and Common Variants Contributing to Schizophrenia and Autism, Mike Talkowski, Massachusetts General Hospital
- The New Kid on the Block: Glia in Mental and Cognitive Disorders, Misha Pletnikov, Johns Hopkins University
- Somatic Mosaicism in the Brain: Diverse Neuronal Genomes and Neuropsychiatric Disorders, Alex Urban, Stanford University
- ISN Symposium Molecular Insights on Organoid and 3D Models to Study Brain Diseases and Development, Chair, Orly Reiner, Weizmann Institute of Science
- Bridging Molecular Genetics with Population Health to Advance Precision Psychiatry, Lea Davis, Vanderbilt University
- Molecular Mechanisms of Autism Spectrum Disorders, Brady Maher, Lieber Institute